Liberty Health Sciences Obtains Approval for Branded Product Development

Liberty Health Sciences (CSE:LHS) received approval from the Florida Department of Health to manufacture and dispense a line of branded products Solei, developed by Aphria (TSX:APH).

As quoted in the press release:

“We are excited to introduce our line of Solei brand products to the U.S. market along with our growing portfolio of premium brands. Liberty is committed to delivering a diverse selection to our important customers in a safe and caring environment,” said George Scorsis, CEO of Liberty Health Sciences. “Consumers in Florida will benefit from Solei’s simplified approach to consuming cannabis and we will offer an assortment of carefully curated products and strains with different experiences.”

Solei brand products will be available in all Liberty Cannabis Education Centers across the state of Florida by mid-October.

Click here to read the full press release.

Source: www.newswire.ca